1. Home
  2. CWH vs XERS Comparison

CWH vs XERS Comparison

Compare CWH & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camping World Holdings Inc.

CWH

Camping World Holdings Inc.

HOLD

Current Price

$6.71

Market Cap

1.1B

ML Signal

HOLD

XERS

Xeris Biopharma Holdings Inc.

HOLD

Current Price

$5.35

Market Cap

936.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWH
XERS
Founded
1966
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
936.3M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
CWH
XERS
Price
$6.71
$5.35
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
$15.89
$10.83
AVG Volume (30 Days)
3.8M
1.9M
Earning Date
04-28-2026
03-02-2026
Dividend Yield
7.43%
N/A
EPS Growth
N/A
100.00
EPS
3.99
N/A
Revenue
$4,792,017,000.00
$49,590,000.00
Revenue This Year
$4.63
$34.22
Revenue Next Year
$5.85
$22.97
P/E Ratio
$1.69
N/A
Revenue Growth
11.83
142.67
52 Week Low
$5.70
$3.81
52 Week High
$19.64
$10.08

Technical Indicators

Market Signals
Indicator
CWH
XERS
Relative Strength Index (RSI) 34.22 34.12
Support Level N/A $4.87
Resistance Level $18.18 $5.49
Average True Range (ATR) 0.45 0.23
MACD 0.17 0.01
Stochastic Oscillator 52.88 11.97

Price Performance

Historical Comparison
CWH
XERS

About CWH Camping World Holdings Inc.

Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Share on Social Networks: